Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Buy
30
+5
+20% +$538 ﹤0.01% 2317
2026
Q1
$3K Hold
25
﹤0.01% 2325
2025
Q4
$3K Hold
25
﹤0.01% 2363
2025
Q3
$2K Hold
25
﹤0.01% 2338
2025
Q2
$2K Hold
25
﹤0.01% 2230
2025
Q1
$2K Hold
25
﹤0.01% 2256
2024
Q4
$2K Hold
25
﹤0.01% 2244
2024
Q3
$3K Buy
+25
New +$2.07K ﹤0.01% 2110

Other funds holding NUVL

Bessemer Group's NUVL Position: Q2 2026 in Review

Bessemer Group increased its Nuvalent (NUVL) stake by 20% in Q2 2026, buying an estimated $538 and bringing the position to 30 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Bessemer Group first reported a position in NUVL in Q3 2024 and has held it in 8 quarters since. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Bessemer Group held 30 shares of Nuvalent worth $4K as of Q2 2026.
  • Bessemer Group bought 5 Nuvalent shares in Q2 2026, an estimated $538.
  • Nuvalent made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2317 holding.
  • Bessemer Group first reported a position in Nuvalent in Q3 2024 and has held it in 8 quarters since.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.